NCT05128461

Brief Summary

Stroke, according to the definition of the World Health Organization (WHO); It is a syndrome characterized by a rapid settlement of signs and symptoms of focal loss of cerebral function without a cause other than vascular causes. As it is known, it is important for patients to regain functional skills in the upper extremities after stroke. Modified-Constraint Induced Movement Therapy (m-CIMT) is a versatile neurorehabilitation technique that aims to improve motor function in the hemiparetic upper extremity and increase its use in daily life activities. However, as in the Covid-19 pandemic, patients cannot always reach rehabilitation services. In such cases, telerehabilitation is a treatment option. There are a limited number of studies in which m-CIMT is applied according to the principle of telerehabilitation, which has become a necessity, especially due to the Covid-19 pandemic. Therefore, the aim of this study is to examine the effects of m-CIMT on upper extremity motor functions in stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2021

Completed
25 days until next milestone

First Posted

Study publicly available on registry

November 22, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

November 22, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2022

Completed
Last Updated

July 11, 2023

Status Verified

July 1, 2023

Enrollment Period

10 months

First QC Date

October 28, 2021

Last Update Submit

July 9, 2023

Conditions

Keywords

StrokeTelerehabilitationmodified-Constraint Induced Movement TherapyUpper Extremity

Outcome Measures

Primary Outcomes (8)

  • Upper extremity motor ability-Baseline

    Wolf Motor Function Test

    Assessment will be conducted before the intervention.

  • Upper extremity motor ability-Post intervention

    Wolf Motor Function Test

    Assessment will be conducted immediately after the intervention.

  • Upper extremity motor function-Baseline

    The Fugl-Meyer Assessment of the Upper Extremity

    Assessment will be conducted before the intervention.

  • Upper extremity motor function-Post intervention

    The Fugl-Meyer Assessment of the Upper Extremity

    Assessment will be conducted immediately after the intervention.

  • Activities of daily living related to the upper extremity-Baseline

    Motor Activity Log-28 (MAL-28) The minimum score that can be obtained from this scale is 0, and the maximum score is 5. Higher scores mean that the level of use and quality of use is better.

    Assessment will be conducted before the intervention.

  • Activities of daily living related to the upper extremity-Post intervention

    Motor Activity Log-28 (MAL-28) The minimum score that can be obtained from this scale is 0, and the maximum score is 5. Higher scores mean that the level of use and quality of use is better.

    Assessment will be conducted immediately after the intervention.

  • Voluntary movement and mobility-Baseline

    Stroke Rehabilitation Assessment of Movement (STREAM)

    Assessment will be conducted before the intervention.

  • Voluntary movement and mobility-Post intervention

    Stroke Rehabilitation Assessment of Movement (STREAM)

    Assessment will be conducted immediately after the intervention.

Secondary Outcomes (8)

  • Isometric hand strength-Baseline

    Assessment will be conducted before the intervention.

  • Isometric hand strength-Post intervention

    Assessment will be conducted immediately after the intervention.

  • Isometric pinch strength-Baseline

    Assessment will be conducted before the intervention.

  • Isometric pinch strength-Post intervention

    Assessment will be conducted immediately after the intervention.

  • manual dexterity performance-Baseline

    Assessment will be conducted before the intervention.

  • +3 more secondary outcomes

Study Arms (2)

Exercise Group

EXPERIMENTAL

The group will receive modified-Constraint Induced Movement Therapy via telerehabilitation and a home exercise program.

Other: ExerciseOther: Home program

Control group

ACTIVE COMPARATOR

The group only will be given a home exercise program.

Other: Home program

Interventions

M-CIMT-based telerehabilitation will be implemented.

Exercise Group

Lower and upper extremity exercises and gait training exercises selected according to the Bobath approach will be given as a home program consisting of 10 same exercises.

Control groupExercise Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age
  • Being diagnosed with stroke for the first time by a doctor
  • Having been diagnosed with stroke at least 1 month ago
  • Mini-Mental Test Score more than or equal 24
  • In the upper extremities; Starting from the angle of full flexion, wrist extension of at least 20° or more, thumb extension or abduction of at least 10°, minimum extension of all other fingers at the metacarpophalangeal and interphalangeal joints
  • Having less than 2.5 points in the pre-treatment evaluation from both parts of MAG-28
  • Being able to stand for 2 minutes without any help by using the upper extremity as a support tool when necessary.
  • Absence of severe pain to affect the treatment
  • Absence of severe spasticity to affect the treatment (spasticity in any joint of the upper extremity ≤ 2 according to the Modified Ashworth Scale)

You may not qualify if:

  • Any orthopedic, vision, hearing or perception problems that may affect the research results
  • Having an additional neurological, cardiovascular, pulmonary or hormonal disorder that would prevent participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Ankara, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Stroke

Interventions

Exercise

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Fettah SAYGILI, PT, M.Sc.

    Research Assistant

    STUDY CHAIR
  • Arzu Güçlü-Gündüz, PT, PhD.

    Professor

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two groups as exercise group and control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 28, 2021

First Posted

November 22, 2021

Study Start

November 22, 2021

Primary Completion

October 1, 2022

Study Completion

October 20, 2022

Last Updated

July 11, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

There is no plan to make IPD data but when the statistical analysis of all data is made, all results will be shared.

Locations